NeOnc Technologies Holdings, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from NeOnc Technologies Holdings, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 100% in 3 years, but profit fell: $295,645 less profit per $100 of extra sales. Lower than almost all Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
2/3 · 1/3Sales grew in 2 of the last 3 years; profit grew in 1 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
−$295,645Sales grew 100% in 3 years, but profit fell: $295,645 less profit per $100 of extra sales.
Lower than almost all Healthcare companies in United States.
Asset Productivity Ratio
+100% / +287%In 3 years sales changed by +100% while total assets changed by +287%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-3.4×Operating cash was negative last year, while some debt falls due within a year.
Higher than 62% of Healthcare companies in United States.
Cash Cushion Ratio
−7%Debt, after subtracting cash, equals 7% of its market value (net debt).
Lower than 76% of Healthcare companies in United States.
Tangible Assets Ratio
82%Of every $100 the company owns, $82 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 52% of Healthcare companies in United States.
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
NeOnc Technologies Holdings, Inc. made a loss over the last year. NeOnc Technologies Holdings, Inc. owes $4.54 for every $1 it owns. NeOnc Technologies Holdings, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossNeOnc Technologies Holdings, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
-4.59NeOnc Technologies Holdings, Inc.'s book value is negative (it owes more than it owns), so P/B is not meaningful.
Market cap
$85 MThe total market value of all of NeOnc Technologies Holdings, Inc.'s shares at today's price (share price × number of shares), smaller than 68% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
NegativeNeOnc Technologies Holdings, Inc.'s net worth is negative ($19 M below zero, balance sheet 30 Jun 2026): it owes more than it owns, so book value per share and P/B are not meaningful.
Owes vs Owns
4.54×NeOnc Technologies Holdings, Inc. owes $4.54 for every $1 it owns, so it owes more than it owns, higher than almost all Healthcare companies in United States.
Dividend yield
NoneNeOnc Technologies Holdings, Inc. does not currently pay a dividend.
Revenue growth
-52%Revenue fell 52% in the year to Dec 2025, and grew 26% a year on average over 3 years.
Profit growth
LossNeOnc Technologies Holdings, Inc. made a loss in each of the last two years.
Profit margin
-155404.4%NeOnc Technologies Holdings, Inc. lost $155404 for every $100 of revenue.
Interest cover
Not coveredNeOnc Technologies Holdings, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtNeOnc Technologies Holdings, Inc. had $6 M more debt than cash (net debt) at Dec 2025.
Questions
How much does NeOnc Technologies Holdings, Inc. owe compared with what it owns?
NeOnc Technologies Holdings, Inc. owes $4.54 for every $1 it owns, so it owes more than it owns, higher than almost all Healthcare companies in United States.
Does NeOnc Technologies Holdings, Inc. pay a dividend?
No. NeOnc Technologies Holdings, Inc. does not currently pay a dividend.
Is NeOnc Technologies Holdings, Inc.'s revenue growing?
Revenue fell 52% in the year to Dec 2025, and grew 26% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.